tsh biopharmoration Ltd (8432) — Capital Reinvestment Ratio
Latest as of June 2025:
0.08x
tsh biopharmoration Ltd (8432) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (NT$42.55 Million) in capital expenditures (NT$3.27 Million). See free cash flow generation of tsh biopharmoration Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
NT$42.55 Million
TWD
Capital Expenditures
NT$3.27 Million
TWD
Data as of
Jun 2025
Most recent filing
tsh biopharmoration Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks tsh biopharmoration Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for tsh biopharmoration Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for tsh biopharmoration Ltd from 2017 to 2024. For live market cap and broader valuation context, see 8432 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | NT$183.77 Million | NT$2.74 Million | ▼ -90.9% |
| 2023 | 0.16x | NT$33.87 Million | NT$5.56 Million | ▼ -69.9% |
| 2022 | 0.55x | NT$34.35 Million | NT$18.73 Million | ▲ +9706.2% |
| 2021 | 0.01x | NT$68.71 Million | NT$382.00K | ▼ -97.3% |
| 2020 | 0.20x | NT$11.61 Million | NT$2.38 Million | ▲ +506.0% |
| 2019 | 0.03x | NT$88.65 Million | NT$3.00 Million | ▼ -64.0% |
| 2018 | 0.09x | NT$62.62 Million | NT$5.88 Million | ▲ +66.8% |
| 2017 | 0.06x | NT$81.13 Million | NT$4.57 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow